Preclinical Trial Results Of GeoVax's Vaccines Demonstrate Potential To Protect Against Development Of AIDS
Wed, 07 Feb 2007 08:00 AM EST
... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company, today reported successful results from a preclinical trial using GeoVax's vaccines for the therapeutic treatment and prevention of Acquired Immunodeficiency Disease Syndrome ("AIDS") in non-human primates. [click link for full article] ...
Related Topics
- Vaccines & Immunizations
- Clinical Trials
- Child Development
- Hearing Aids
- Fetal Development
- HIV/AIDS & STDs
- Teen Development
- Community Development
- Acquired Immune Deficiency Syndrome
- AIDS - Living and Coping
- Polio Vaccine & Origin of HIV/AIDS
- Pediatric Aids
- AIDS and Infections
- AIDS and Pregnancy
- Polio Vaccine & Cancer
- Polio Vaccine
- Infant and Toddler Development
- Ovarian Low Malignant Potential Tumors
- Ovarian Low Malignant Potential Tumor
- Vaccine Development

Not Signed In -


